Colo 320 cells are colonic carcinoma cells known to express abundant c-myc mRNA. Based on the response ofseveral hematopoietic cell lines to chemical inducers of differentiation, we reasoned that such agents might have similar inductive activity in Colo 320 cells. Accordingly, we exposed Colo 320 cells to 5 mM sodium butyrate (NaBT) for 7 d. C-myc expression decreased threefold and self-replicative potential decreased (defined as a > 60% decrease in colony-forming capacity in soft agar that did not contain inducer). In an effort to demonstrate a direct cause and effect between myc expression and the colonyforming capacity of Colo 320 cells, we exposed these cells to a 15-base antisense c-myc oligonucleotide (complementary to the translation initiation region of exon II). Cells were also exposed to equimolar (20 AM) amounts of sense and missense oligonucleotides. Subsequently, cells were incubated at 10, 20, 30, and 40 gzM antisense DNA for 16 h, then washed and plated in oligonucleotide-free agar medium. We demonstrated that: (a) the oligomers were stable in the extracellular medium and in the cell cytoplasm; (b) the uptake of the oligonucleotides was 0.7%; (c) sense and missense oligonucleotides had no effect on colony-forming capacity; and (d) the antisense c-myc oligonucleotide resulted in a 40-75% concentration-dependent decrease in colony-forming capacity. The specific inhibition of colony-forming capacity by antisense DNA suggests that the role of myc expression in Colo 320 cells is similar to its role in hematopoiesis, and that the failure to inhibit myc expression maintains colony-forming capacity. This system provides a new strategy for inducing differentiation and may provide further insight into the genetic factors that govern the process of colonic carcinogenesis. (J. Clin.
Introduction
The c-myc gene is highly expressed in proliferating, undifferentiated cells, and encodes for a nuclear phosphoprotein that is thought to participate in functions that control cell proliferation and differentiation. The myc proteins have been more recently described as interacting with Max, a basic helix-loophelix zipper protein, and both may belong to a general class of DNA-binding transcription factors ( 1, 2) . The evidence for linkage of myc expression and the undifferentiated phenotype has been demonstrated in several cell types, but has most consistently been found in cells ofhematopoietic origin (3, 4) . Gowda et al. (5) and Emilia et al. (6) demonstrated that the c-myc gene was expressed in immature normal myeloid precursor cells, but was repressed in terminally differentiated granulocytes and their immediate precursors. In addition, human acute myeloid leukemic cells that fail to differentiate in vitro also fail to suppress c-myc transcription (6) . The linkage of c-myc expression with hematopoietic cellular differentiation has been formally tested in two ways. First, Dmitrovsky et al. (7) noted that murine erythroleukemia cells transfected with a highly promoted human c-myc gene no longer exhibited its normally inducible differentiation program. Secondly, Holt et al. (8) demonstrated that repression of c-myc expression using antisense c-myc ohgodeoxyribonucleotides induced differentiation of HL-60 myeloid leukemic cells. Therefore, in hematopoietic cells the protein myc functions to maintain the primitive phenotype and the repression of c-myc is a necessary and sufficient step to commit certain primitive cells to differentiate.
Because most nonhematopoietic tumor cells also express c-myc, we reasoned that the differentiation function of c-myc was likely a broadly applicable principle in multiple lineages (9) . Accordingly, we tested the applicability of this model in Colo 320 cells, a human colonic carcinoma cell line. They were established from a primary human colonic carcinoma and were noted to secrete ACTH, PTH, and serotonin (10) . Hence, these were thought to be representative of a neuroendocrine cell type, one of the three cell types found in human colonic mucosa (1 1 (20, (24) (25) (26) (27) Oligonucleotide-induced differentiation Antisense, sense, and missense c-myc oligonucleotides were obtained from the Midland Certified Reagent Co., Midland, TX. These 1 5-base deoxynucleotides have been described previously (8) . The antisense oligonucleotide was complementary to the translation initiation region ofthe c-myc gene located at the beginning ofexon II. To insure that the missense oligonucleotide (12 mismatched bp) did not inadvertently anneal to a known sequence, the European Molecular Biology Library (IntelliGenetics, Mountain View, CA) was searched for homologous sequences (allowing up to three mismatched base pairs). The missense oligonucleotide was complementary only to a few reading frames of HTLV-I and a portion of the neural cell adhesion molecule, NCAM. Each oligomer was labeled using T4 polynucleotide kinase (Boehringer-Mannheim Biochemicals) and a-[32PIATP (sp act 6,000
Ci/mM; New England Nuclear). Cell suspensions were evaluated for stability and uptake of the oligonucleotide, as previously described (8, 33) , and the resulting effect on colony-forming capacity.
Stability. To determine that the oligonucleotides were stable under experimental conditions, 5' end-labeled pentadecadeoxynucleotides were incubated for 16 h at 37°C in PBS alone, in the presence of 5 X I08 Colo 320 cells in RPMI with 10% heat-inactivated FCS, and in medium and 10% serum alone. Aliquots from each of these fractions were ethanol precipitated and electrophoresed in a 7 M urea, 8% polyacrylamide gel.
Cellular uptake ofoligonucleotide. 5 X I05 Colo 320 cells in 100 M1 RPMI with heat-inactivated FCS were exposed to 10 MM of 5' end-labeled oligonucleotide for 16 h at 37°C. FCS was heated to 65°C for 30 min to inactivate DNases. The cells were washed twice and the supernatants saved (extracellular fraction). Nonidet-P40 lysis buffer was then added, and nuclei were prepared by centrifugation. This phase represented the cytoplasmic fraction. The remaining material was the nucleoplasmic fraction. All uptake experiments were performed in duplicate. The percent uptake by the cells was calculated by the number of counts in the cytoplasmic fractions/total number of counts in the cell pellet, cell wash, and culture-medium supernatant (8, 33) . To insure that the radioactive counts in the cytoplasmic fraction was due to labeled probe rather than a labeled phosphate, ethanol-precipitated samples of the cytoplasmic fraction were electrophoresed in 7 M urea/8% polyacrylamide gels and autoradiographed.
Oligonucleotide exposure. 20 
Results
Sodium butyrate inhibited c-myc mRNA accumulation and colony-forming capacity in Colo 320 cells. Myc expression began to decrease after 2 d exposure to sodium butyrate (see Fig.  1 ), and after a 5-d exposure the cells showed a significant decrease (2 60%) in colony-forming capacity (see Fig. 2 ). Other markers of differentiation such as morphological changes, alkaline phosphatase synthesis, and immunohistochemical stains were not helpful. Tumors formed in 9 ofthe 10 possible cause and effect relationship between c-myc expression and colony-forming capacity by using antisense methodology. The uptake of 5' end-labeled oligonucleotides (antisense, sense, and missense) by Colo 320 cells was 0.6-0.8% after 16 h. Denaturing gel electrophoresis ofthe labeled oligonucleotide in the extracellular medium and in the cytoplasm of the cultured cells demonstrated that the oligonucleotide was stable for up to 16 h in the presence of cells (Fig. 3) .
Colony-forming capacity was decreased by 50% in the antisense-exposed cells, but not in the cells exposed to sense or missense oligonucleotides (Fig. 4) . Moreover, exposure to increasing doses of antisense oligonucleotide resulted in a dosedependent decrease in colony-forming capacity (Fig. 5) . Cell viability was 95% in both control and antisense exposed cells when assessed by trypan blue exclusion. (20) . Hence, we were unable to detect differences in tumor histology, size, or metastases between animals receiving control cells and those receiving cells exposed to sodium butyrate for 7 d. We concluded that the loss of colony-forming capacity was the most sensitive and quantitative measure of an induced commitment towards differentiation. The fact that c-myc repression preceded the decline in colony-forming capacity was compatible with the notion that the decrease in myc transcription was the cause, and not the result, ofthe decreased colony-forming capacity.
To formally demonstrate a direct cause and effect relationship between c-myc repression and inhibition of colony-forming capacity, we utilized an antisense oligodeoxynucleotide method. We demonstrated that the c-myc antisense and control oligonucleotides were stable in the presence of Colo 320 cells and took up the oligonucleotide intact. We noted a dosedependent decrease in colony-forming capacity after cells were exposed to antisense oligonucleotide. The lack of effect by equimolar amounts of sense or missense 15-base nucleotides on colony-forming capacity implies a specific inhibition by myc antisense. This supports the conclusion that myc expression is required to maintain colony-forming capacity and its repression is sufficient to inhibit it.
These data strongly suggest that the role of c-myc in Colo 320 cell differentiation is similar to its role in hematopoiesis, and that unrepressed myc expression maintains this colonyforming capacity and represents a primitive cell phenotype. Future studies designed to clarify the molecular determinants of c-myc repression in normal colonic epithelial cells may yield important information about one of the fundamental molecular defects in colorectal carcinoma cells.
